Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma

作者：Adam Charles Yopp, M. C. Chen, Ann-Lii Cheng, Ahmed Kaseb, Masatoshi Kudo, Han Chu Lee, Edward Cha, Stephen Paul Hack, Qinshu Lian, Jessica H. Spahn, Chun Wu, Shukui Qin, Pierce Kah-Hoe Chow · 发表于：Journal of Hepatology · 年份：2026 · DOI：10.1016/j.jhep.2026.01.006 · 被引用次数：34 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Cholangiocarcinoma and Gallbladder Cancer Studies、Liver physiology and pathology